semaglutide and kidney Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome FDA approves Ozempic to reduce

Most booked Start here79 Initial Consultation A focused 60-minute session to understand your situation, identify what is getting in the way and create a clear plan forward

BPC-157 shows promising potential for plantar fasciitis based on its demonstrated ability to accelerate tendon and ligament healing in research studies

Safety Takeaway: While the evidence from controlled human trials suggests a manageable adverse event profile, the products full extent of long-term safety, especially regarding chronic and rare side effects, remains undetermined until the completion of ongoing large-scale clinical programs and subsequent regulatory review and approval

In May 2022, Mounjaro was approved by the FDA for the treatment of type 2 diabetes, though many people have also used it off-label for weight loss